[
  {
    "ts": null,
    "headline": "The Cost Of Being Totally Out Of Sync With An AI-Driven Speculative Market",
    "summary": "The Cost Of Being Totally Out Of Sync With An AI-Driven Speculative Market",
    "url": "https://finnhub.io/api/news?id=6e62a2e456da400f7c738565e4933f0a8ac8834daa15a3cebda04eca0df0606b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771971900,
      "headline": "The Cost Of Being Totally Out Of Sync With An AI-Driven Speculative Market",
      "id": 139203669,
      "image": "",
      "related": "IQV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=6e62a2e456da400f7c738565e4933f0a8ac8834daa15a3cebda04eca0df0606b"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats",
    "summary": "IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 19, Jailendra Singh from Truist Financial reiterated his Buy rating for IQVIA Holdings Inc. (NYSE:IQV). He lowered the price target on the stock from $290 to $274, which still offers an impressive upside potential […]",
    "url": "https://finnhub.io/api/news?id=f8bada355308adf34c688357f44dc1a33b49fd6f699384e9a068515e28316667",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771961633,
      "headline": "IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats",
      "id": 139201015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 19, Jailendra Singh from Truist Financial reiterated his Buy rating for IQVIA Holdings Inc. (NYSE:IQV). He lowered the price target on the stock from $290 to $274, which still offers an impressive upside potential […]",
      "url": "https://finnhub.io/api/news?id=f8bada355308adf34c688357f44dc1a33b49fd6f699384e9a068515e28316667"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Consider Right Now and 2 We Turn Down",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 10.6% over the past six months while the S&P 500 was up 7.3%.",
    "url": "https://finnhub.io/api/news?id=7d9aff69088abdad8327b16ea161ca21ee83e12ebcf78ff0774ea1a9995fe49e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771908270,
      "headline": "1 Healthcare Stock to Consider Right Now and 2 We Turn Down",
      "id": 139193250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 10.6% over the past six months while the S&P 500 was up 7.3%.",
      "url": "https://finnhub.io/api/news?id=7d9aff69088abdad8327b16ea161ca21ee83e12ebcf78ff0774ea1a9995fe49e"
    }
  }
]